Coronavirus and SARS-CoV-2

Coronavirus disease (COVID-19) is a new infection and virulent respiratory disease occurs when virus-containing particles expired by an infected person, either respiratory droplets or aerosols effectuated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an uncommon severe acute respiratory syndrome coronavirus. Although SARS-CoV-2 has a response for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyper inflammation. The virus predominantly spreads between people through close contact and by means of respiratory droplets induced from coughs or sneezes and it mainly enters human cells by binding to the receptor angiotensin converting enzyme 2.

Most common symptoms are:

  • Fever
  • Dry cough
  • Tiredness

Related Conference of Coronavirus and SARS-CoV-2

September 22-23, 2025

6th World Congress on Neuroimmunology and Neuroinfectious Diseases

Amsterdam, Netherlands
October 16-17, 2025

39th International Conference on Immunology

Amsterdam, Netherlands
May 18-19, 2026

17th Global Summit on Immunology and Cell Biology

Paris, Aland Islands

Coronavirus and SARS-CoV-2 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in